Suspected or Documented Gram-negative Bacterial Infection
2 clinical trials · Condition
◉ Watch Suspected or Documented Gram-negative Bacterial Infection
| Record | Firm | Date |
|---|---|---|
| Safety, Tolerability, Efficacy and Pharmacokinetics of Imipenem/Cilastatin/Relebactam (MK-7655A) in Pediatric Participants With Gram-negative Bacterial Infection (MK-7655A-021) (NCT03969901) | Merck Sharp & Dohme LLC | 2019-10-08 |
| A Pharmacokinetics Study of MK-7655A in Pediatric Participants With Gram-negative Infections (MK-7655A-020) (NCT03230916) | Merck Sharp & Dohme LLC | 2017-11-06 |
Track Suspected or Documented Gram-negative Bacterial Infection automatically
Every clearance here is in the API, with alerts when new ones post.